LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Cordless Handheld Device Uses Vibrations to Eliminate Fingerstick Pain for Blood Sugar Testing

By LabMedica International staff writers
Posted on 10 Nov 2021
Print article
Image: DigiVibe Glucose Monitoring Device (Photo courtesy of BING Innovations, LLC)
Image: DigiVibe Glucose Monitoring Device (Photo courtesy of BING Innovations, LLC)

A new portable tool uses innovative vibration technology to improve the ease of diabetes management.

BING Innovations, LLC (Boca Raton, FL, USA) has launched DigiVibe, a cordless handheld device that uses vibrations to eliminate the pain of getting the finger pricked. Specifically designed for blood glucose monitoring, DigiVibe applies vibration directly to the finger, blocking pain signals to the brain and helping to make the process more tolerable for both children and adults.

While many people only get their finger-pricked at their annual checkup, for those with diabetes, glucose monitoring means having to prick their finger three or more times each day. DigiVibe, an FDA-registered and CE-certified device, has been created to reduce the pain and anxiety of checking glucose levels, whether a person is not keen on needles or just weary of repeated finger pricks. The easy-to-use and portable device adheres to any flat surface for hands-free use, making self-testing and diabetes management easier and more convenient than ever before. For a doctor who regularly deals with diabetic patients or an individual who must test their glucose levels regularly, the DigiVibe device can make the process easier and virtually painless - in as little as 12 seconds.

The DigiVibe Starter Kit includes a sleek carrying case containing one DigiVibe device, stand and tip, lancing device, five 30-gauge lancets, and one AA lithium battery. The battery is designed to last for approximately three months or roughly 450 finger sticks for a single user. Plus, there is enough space in the carrying case to fit one’s regular test strips and glucose testing device. Additional accessories or refills of supplies can also be ordered anytime on the DigiVibe website. One-time use disposable tips and lancing devices are also available for medical practitioners.

"The conventional way to test blood sugar for diabetes is often associated with pain, discomfort, and even fear, but DigiVibe has set out to dramatically make this experience better," said Dr. Marcelo Bendix, Endocrinologist and DigiVibe Medical Advisor. "Pain and finger soreness are among the top reasons diabetics sometimes skip blood glucose testing, which is not only dangerous, but makes it quite difficult for them to effectively manage diabetes. DigiVibe is truly a game-changer; it will allow patients to stay on top of their glucose testing and no longer fear the dreaded finger-prick they have to endure in the doctor's office and at home."

Related Links:
BING Innovations, LLC 

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Centromere B Assay
Centromere B Test
New
Respiratory QC Panel
Assayed Respiratory Control Panel

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.